EDMONTON, Alberta, Feb. 27 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it will begin shipping into another Middle East country starting March 1, 2006. The Company has received an initial order to begin shipping the VScan HIV test kit into Egypt. The initial order will be shipped on March 1, 2006. This is expected to be the first of many orders that will be shipped to Egypt. Since participating in the medical show in Dubai, the Company has received numerous requests for information about its test kits, particularly the VScan HIV test kit and has received orders that it started shipping last week. Egypt is the fourth Middle East country that has placed and paid for an order to be shipped since the medical show in Dubai. The Company also continues to receive additional orders from its distributor in Nigeria. New orders to Nigeria are being shipped the first week in March 2006. The VScan HIV rapid test kit has established a reputation as being accurate, fast, and easy to use. It has shown many times that it out performs all other rapid test kits when it comes to use in remote areas using whole blood. It does not require trained medical personnel or medical facilities. It detects the first antigen formed after HIV infection, IgM which is detectable in the blood within 2 to 11 days of infection. Other test kits only detect the IgG antigen which is not detectable in the blood for 180 days. By this time, the immune system has been compromised and the antiviral drugs do not work as well or greater dosages are required which results in additional or significantly more severe side effects. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or media contact Bill Whitehead at (416) 822 5883 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/. NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. First Call Analyst: FCMN Contact: DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot, +1-780-430-6363, or media contact, Bill Whitehead, +1-416-822-5883, both of Medical Services International Inc. Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright